Increased levels of C5a have been described in plasma as well as in the leukocytes of the peripheral blood of patients with ALS (28), and a significant upregulation of ficolin-3 which increase the potential of LP complement activation also been reported (54). The gene discussed is C5; the disease is amyotrophic lateral sclerosis.